O'Shaughnessy Asset Management, LLC Innoviva, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

$12.1 Billion
Q1 2025

A detailed history of O'Shaughnessy Asset Management, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 247,608 shares of INVA stock, worth $4.57 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

247,608

Previous 263,870 6.16%

Holding current value

$4.57 Million

Previous $4.58 Million 1.94%

% of portfolio

0.04%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$17.21 - $18.98 $279,869 - $308,652	-16,262 Reduced 6.16%	247,608 $4.49 Million
Q4 2024 Feb 12, 2025	BUY	$17.35 - $20.32 $142,964 - $167,436	8,240 Added 3.22%	263,870 $4.58 Million
Q3 2024 Nov 12, 2024	BUY	$16.33 - $20.04 $712,036 - $873,804	43,603 Added 20.56%	255,630 $4.93 Million
Q2 2024 Aug 14, 2024	BUY	$14.4 - $16.4 $2 Million - $2.28 Million	138,961 Added 190.19%	212,027 $3.48 Million
Q1 2024 May 13, 2024	BUY	$14.56 - $16.78 $554,444 - $638,982	38,080 Added 108.84%	73,066 $1.11 Million
Q4 2023 Feb 09, 2024	BUY	$12.32 - $16.27 $161,589 - $213,397	13,116 Added 59.97%	34,986 $561,000
Q3 2023 Nov 13, 2023	SELL	$12.37 - $13.89 $45,199 - $50,754	-3,654 Reduced 14.32%	21,870 $284,000
Q2 2023 Aug 11, 2023	SELL	$11.39 - $13.72 $557,460 - $671,497	-48,943 Reduced 65.72%	25,524 $324,000
Q1 2023 May 12, 2023	SELL	$10.73 - $13.6 $472,892 - $599,379	-44,072 Reduced 37.18%	74,467 $837,000
Q4 2022 Feb 10, 2023	SELL	$11.8 - $13.78 $1.13 Million - $1.31 Million	-95,409 Reduced 44.59%	118,539 $1.57 Million
Q3 2022 Nov 14, 2022	SELL	$11.61 - $15.22 $70,495 - $92,415	-6,072 Reduced 2.76%	213,948 $2.48 Million
Q2 2022 Aug 11, 2022	SELL	$14.32 - $19.88 $346,228 - $480,658	-24,178 Reduced 9.9%	220,020 $3.25 Million
Q1 2022 May 13, 2022	BUY	$15.39 - $20.25 $815,239 - $1.07 Million	52,972 Added 27.7%	244,198 $4.73 Million
Q4 2021 Feb 11, 2022	BUY	$15.91 - $18.72 $641,379 - $754,659	40,313 Added 26.71%	191,226 $3.3 Million
Q3 2021 Nov 10, 2021	BUY	$13.06 - $17.24 $451,732 - $596,314	34,589 Added 29.74%	150,913 $2.52 Million
Q2 2021 Aug 09, 2021	BUY	$11.45 - $13.96 $366,010 - $446,245	31,966 Added 37.89%	116,324 $1.56 Million
Q1 2021 May 14, 2021	SELL	$11.06 - $12.87 $69,379 - $80,733	-6,273 Reduced 6.92%	84,358 $1.01 Million
Q4 2020 Feb 11, 2021	SELL	$9.33 - $12.48 $70,581 - $94,411	-7,565 Reduced 7.7%	90,631 $1.12 Million
Q3 2020 Nov 12, 2020	BUY	$10.33 - $14.49 $644,684 - $904,306	62,409 Added 174.39%	98,196 $1.03 Million
Q2 2020 Aug 13, 2020	BUY	$11.49 - $15.26 $376,630 - $500,207	32,779 Added 1089.73%	35,787 $500,000
Q1 2020 May 13, 2020	SELL	$8.11 - $15.23 $1.28 Million - $2.41 Million	-158,124 Reduced 98.13%	3,008 $35,000
Q4 2019 Feb 12, 2020	SELL	$10.28 - $14.38 $320,540 - $448,382	-31,181 Reduced 16.21%	161,132 $2.28 Million
Q3 2019 Nov 14, 2019	SELL	$10.05 - $14.55 $521,966 - $755,683	-51,937 Reduced 21.26%	192,313 $2.03 Million
Q2 2019 Aug 07, 2019	SELL	$13.1 - $14.95 $299,793 - $342,130	-22,885 Reduced 8.57%	244,250 $3.55 Million
Q1 2019 May 10, 2019	BUY	$13.69 - $20.06 $1.98 Million - $2.89 Million	144,290 Added 117.46%	267,135 $0
Q4 2018 Feb 12, 2019	BUY	$13.96 - $18.26 $1.07 Million - $1.4 Million	76,641 Added 165.88%	122,845 $2.15 Million
Q3 2018 Nov 06, 2018	BUY	$13.63 - $15.7 $367,233 - $423,005	26,943 Added 139.88%	46,204 $704,000
Q2 2018 Aug 10, 2018	BUY	$13.44 - $17.59 $258,867 - $338,800	19,261 New	19,261 $266,000

Others Institutions Holding INVA

# of Institutions

260

Shares Held

75.2M

Call Options Held

2.3K

Put Options Held

2.4K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.29B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.

Account

O'Shaughnessy Asset Management, LLC Innoviva, Inc. Transaction History